S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

eFFECTOR Therapeutics (EFTR) Institutional Ownership

$1.78
-0.11 (-5.82%)
(As of 04/18/2024 ET)

Institutional Ownership Changes (13F Filings) for eFFECTOR Therapeutics (NASDAQ:EFTR)

Current
Institutional Ownership
Percentage
57.67%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$67.60M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$4.92M
Get EFTR Insider Trade Alerts

Want to know when executives and insiders are buying or selling eFFECTOR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

EFTR Institutional Buying and Selling by Quarter

eFFECTOR Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.574,413$268K0.0%+42.2%22.264%
2/15/2024Vanguard Group Inc.574,413$268K0.0%+42.2%22.221%
2/13/2024Northern Trust Corp160,812$75K0.0%+336.8%6.233%
11/13/2023Column Group LLC4,026,224$2.42M1.6%-6.6%9.496%
11/2/2023Sonora Investment Management Group LLC125,000$75K0.0%N/A0.295%
8/11/2023Renaissance Technologies LLC880,908$731K0.0%+512.2%2.078%
6/5/2023EP Wealth Advisors LLC17,607$1.65M0.0%N/A0.042%
5/16/2023Sea Otter Advisors LLC263,942$93K0.0%N/A0.622%
5/12/2023Renaissance Technologies LLC143,900$51K0.0%-34.6%0.339%
5/5/2023Carlyle Group Inc.4,822,114$1.69M0.1%N/A11.373%
2/15/2023CI Private Wealth LLC275,442$118K0.0%N/A0.658%
2/13/2023Renaissance Technologies LLC219,900$94K0.0%+12.5%0.525%
11/15/2022Two Sigma Investments LP47,223$27K0.0%N/A0.113%
11/15/2022Vanguard Group Inc.429,043$245K0.0%-17.0%1.024%
11/14/2022Renaissance Technologies LLC195,399$112K0.0%+567.2%0.466%
8/16/2022Callan Capital LLC20,000$28K0.0%N/A0.048%
8/13/2022Renaissance Technologies LLC29,288$42K0.0%N/A0.071%
8/2/2022Resolute Financial LLC30,000$43K0.0%N/A0.072%
8/1/2022Parallel Advisors LLC1,693,559$2.41M0.1%+150.0%4.092%
5/16/2022State Street Corp17,000$68K0.0%N/A0.041%
4/28/2022Parallel Advisors LLC677,452$2.74M0.1%N/A1.637%
2/15/2022SR One Capital Management LP6,822,114$56.49M31.9%N/A16.898%
2/9/2022Alps Advisors Inc.51,942$430K0.0%N/A0.129%
2/3/2022OUP Management Co. LLC1,025,697$8.49M3.8%N/A2.541%
11/16/2021Verition Fund Management LLC24,667$347K0.0%N/A0.061%
11/15/2021Abingworth LLP4,822,114$67.03M15.2%N/A11.964%
11/15/2021Sectoral Asset Management Inc2,882,744$40.50M3.4%N/A7.153%
(Data available from 1/1/2016 forward)

EFTR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of EFTR shares?

During the previous two years, 14 institutional investors and hedge funds held shares of eFFECTOR Therapeutics. The most heavily invested institutionals were Column Group LLC ($2.42M), Parallel Advisors LLC ($2.41M), Carlyle Group Inc. ($1.69M), EP Wealth Advisors LLC ($1.65M), Renaissance Technologies LLC ($731K), Vanguard Group Inc. ($268K), and CI Private Wealth LLC ($118K).Learn more on EFTR's institutional investors.

What percentage of eFFECTOR Therapeutics stock is owned by institutional investors?

57.67% of eFFECTOR Therapeutics stock is owned by institutional investors. Learn more on EFTR's institutional investor holdings.

Which institutional investors have been buying eFFECTOR Therapeutics stock?

Of the 13 institutional investors that purchased eFFECTOR Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Carlyle Group Inc. ($4.82M), Parallel Advisors LLC ($1.69M), Renaissance Technologies LLC ($956.91K), Vanguard Group Inc. ($340.77K), CI Private Wealth LLC ($275.44K), Sea Otter Advisors LLC ($263.94K), and Sonora Investment Management Group LLC ($125K).

How much institutional buying is happening at eFFECTOR Therapeutics?

Institutional investors have bought a total of 8,733,567 shares in the last 24 months. This purchase volume represents approximately $182.37M in transactions.

Which eFFECTOR Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold eFFECTOR Therapeutics stock in the last 24 months: Column Group LLC ($283.11K), Vanguard Group Inc. ($87.76K), and Renaissance Technologies LLC ($76K).

How much institutional selling is happening at eFFECTOR Therapeutics?

Institutional investors have sold a total of 446,860 shares in the last 24 months. This volume of shares sold represents approximately $6.17M in transactions.


This page (NASDAQ:EFTR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners